Long-term Study of SYR-472

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

To evaluate the safety and efficacy of long-term treatment with SYR-472 in diabetic patients.

Phase 3

Takeda

Hypoglycemic Agents